Latest Articles

Publication Date
Guided immunotherapy for residual solid tumor: integrating platelets and CAR T cells to reduce post-surgical recurrence.

Postoperative recurrence remains a major obstacle to durable remission in patients with solid tumors, even after complete macroscopic resection. Growing evidence suggests that surgery creates a transient yet highly permissive …

Published: July 3, 2026, midnight
Cartherics emerges as Asia Pacific leader in off-the-shelf immune cell therapy - BiotechDispatch

Cartherics emerges as Asia Pacific leader in off-the-shelf immune cell therapy BiotechDispatch

Published: July 2, 2026, 12:04 a.m.
Cartherics emerges as Asia Pacific leader in off the shelf immune cell therapy - PharmaDispatch

Cartherics emerges as Asia Pacific leader in off the shelf immune cell therapy PharmaDispatch

Published: July 1, 2026, 1:09 a.m.
Cartherics secures Japanese patent to bolster cell therapy push - Biotech Dispatch

Cartherics secures Japanese patent to bolster cell therapy push Biotech Dispatch

Published: June 11, 2026, 1:50 a.m.
Cartherics secures Japanese patent to bolster cell therapy push - PharmaDispatch

Cartherics secures Japanese patent to bolster cell therapy push PharmaDispatch

Published: June 10, 2026, 12:17 a.m.
Biomarkers for Endometrial Receptivity: Implications for Infertility, Implantation Failure, and Advances in Diagnosis and Treatment.

Female infertility affects millions of women worldwide and is frequently caused by ovulatory disorders and uterine pathologies. Among these, endometrial abnormalities play a central role, especially in cases of embryo …

Published: May 9, 2026, midnight
Stem cell therapy-based approaches in experimental endometriosis: a systematic review.

Published: April 17, 2026, midnight
CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma - Oncology Central

CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma Oncology Central

Published: March 23, 2026, 9:45 a.m.
CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma - Oncology Central

CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma Oncology Central

Published: March 23, 2026, 9:45 a.m.
New CAR-NKT cell therapy shows promise against aggressive endometrial cancer - News-Medical

New CAR-NKT cell therapy shows promise against aggressive endometrial cancer News-Medical

Published: March 17, 2026, 1:30 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!